Ginkgo Bioworks
North America, Massachusetts, United States, Boston
Description
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
Investor Profile
Ginkgo Bioworks has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Biotechnology, Health Care, Renewable Energy.
Stage Focus
- Series A (57%)
- Series Unknown (14%)
- Post Ipo Equity (14%)
- Seed (14%)
Country Focus
- United States (86%)
- Israel (14%)
Industry Focus
- Biotechnology
- Health Care
- Renewable Energy
- Agriculture
- Environmental Consulting
- Chemical Engineering
- Cleantech
- Manufacturing
- Therapeutics
- Environmental Engineering
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
